Bleomycin Chemotherapy

Content: 
Front Matter, Page iii
Copyright, Page iv
CONTRIBUTORS, Pages xiii-xvii
PREFACE, Page xix
Chapter 1 - BLEOMYCIN: MORE THAN A DECADE LATER, Pages 3-35, Stephen K. Carter
Chapter 2 - CLINICAL PHARMACOLOGY OF BLEOMYCIN, Pages 37-43, Branimir Ivan Sikic
Chapter 3 - CHEMOTHERAPY OF TESTICULAR CARCINOMA: AN OVERVIEW, Pages 47-58, Brian J. Lewis
Chapter 4 - THE MEMORIAL HOSPITAL EXPERIENCE IN THE MANAGEMENT OF TESTICULAR GERM-CELL TUMORS, Pages 59-68, Robert B. Golbey
Chapter 5 - EFFECTIVE TREATMENT OF MALIGNANT OVARIAN GERM-CELL TUMORS WITH CISPLATIN, VINBLASTINE, AND BLEOMYCIN (PVB), Pages 69-76, Robert W. Carlson, Branimir Ivan Sikic
Chapter 6 - THE ROLE OF CHEMOTHERAPY IN THE TREATMENT OF HEAD AND NECK CANCER, Pages 79-93, Charlotte D. Jacobs
Chapter 7 - HEAD AND NECK CANCER: BLEOMYCIN PLUS RADIOTHERAPY, Pages 95-107, Karen K. Fu
Chapter 8 - THE ROLE OF INDUCTION CHEMOTHERAPY IN COMBINED-MODALITY TREATMENT PROGRAMS, Pages 109-115, Robert E. Wittes
Chapter 9 - INDUCTION CHEMOTHERAPY IN THE TREATMENT OF HEAD AND NECK CANCER: SUNY BUFFALO AND VAMC EXPERIENCE, Pages 117-124, Monica B. Spaulding
Chapter 10 - HODGKIN'S DISEASE: AN OVERVIEW AND ABVD STUDIES IN MILAN, Pages 127-135, Valeria Bonfante, Armando Santoro, Emilio Bajetta, Pinuccia Valagussa, Simonetta Viviani, Roberto Buzzoni, Gianni Bonadonna
Chapter 11 - BLEOMYCIN IN COMBINATION WITH MOPP IN THE MANAGEMENT OF ADVANCED HODGKIN'S DISEASE: A SOUTHWEST ONCOLOGY GROUP EXPERIENCE, Pages 137-153, Charles A. Coltman Jr., Petre N. Grozea, Stephen E. Jones, Edward J. De Persio, Dennis O. Dixon
Chapter 12 - COMBINED-MODALITY STUDIES IN THE TREATMENT OF HODGKIN'S DISEASE, Pages 155-168, Richard T. Hoppe
Chapter 13 - THE NON-HODGKIN'S LYMPHOMAS: AN OVERVIEW, Pages 169-179, Sandra J. Horning
Chapter 14 - NON-HODGKIN'S LYMPHOMAS: MILAN STUDIES, Pages 181-186, Valeria Bonfante, Armando Santoro, Emilio Bajetta, Pinuccia Valagussa, Simonetta Viviani, Roberto Buzzoni, Gianni Bonadonna
Chapter 15 - BACOP AND RELATED STUDIES IN NON-HODGKIN'S LYMPHOMA, Pages 187-199, Arthur T. Skarin, George P. Canellos
Chapter 16 - A REASSESSMENT OF BLEOMYCIN IN LUNG CANCER AND OTHER INTRATHORACIC NEOPLASMS, Pages 203-214, Franco M. Muggia, Daniel D. Von Hoff
Chapter 17 - NON-SMALL-CELL LUNG CANCER: BLEOMYCIN PLUS ETOPOSIDE AND CISPLATIN, Pages 215-224, David Osoba, James J. Rusthoven, Kathryn Turnbull, Ida Ackerman, Martin P. Berry, Pamela A. Catton, Geoffrey M. Davies, Hensley A.B. Miller, Glen A. Taylor, Peter M. Webster, William K. Evans, Frances A. Shepherd, Martin E. Blackstein, Martin Levitt
Chapter 18 - CERVICAL CANCER: BLEOMYCIN STUDIES—AN OVERVIEW, Pages 227-238, David S. Alberts, Silvio Aristizabal, Sheldon Weiner, Earl A. Surwit
Chapter 19 - BLEOMYCIN IN CERVICAL CARCINOMA: PROTOCOLS OF THE NORTHERN CALIFORNIA ONCOLOGY GROUP, Pages 239-244, Samuel C. Ballon, Branimir Ivan Sikic
Chapter 20 - PULMONARY TOXICITY OF BLEOMYCIN, Pages 247-254, Branimir Ivan Sikic
Chapter 21 - BLEOMYCIN: THE SEARCH FOR OTHER INDICATIONS, Pages 257-273, Arthur C. Louie
Chapter 22 - PEPLOMYCIN AND TALLYSOMYCIN S10b: TWO BLEOMYCIN ANALOGS, Pages 277-287, Arthur C. Louie, Robert C. Gaver, Marcel Rozencweig, Raymond H. Farmen, Robert L. Comis, C.R. Franks
Chapter 23 - NEW ANALOGS AND DERIVATIVES OF BLEOMYCIN, Pages 289-301, Hamao Umezawa, Tomohisa Takita, Sei-ichi Saito, Yasuhiko Muraoka, Katsutoshi Takahashi, Hisao Ekimoto, Seiki Minamide, Kiyohiro Nishikawa, Takeyo Fukuoka, Tokuji Nakatani, Akio Fujii, Akira Matsuda
Chapter 24 - BLEOMYCIN: FUTURE PROSPECTS, Pages 305-311, Robert E. Wittes
Chapter 25 - BLEOMYCIN IN CHEMOTHERAPY: SUMMARY AND CLOSING REMARKS, Pages 313-316, Edwin C. Cadman